On September 15, METIS TECHBIO-P rose 5.54% in regular trading, trading at HK$15.88 per share, with turnover of HK$31.65 million. The rebound comes after the stock endured consecutive sessions of selling pressure following its inclusion in the Stock Connect program.

METIS TECHBIO-P was officially added to the Hong Kong Stock Connect eligible securities list on September 7, a move that initially unlocked southbound capital access for mainland investors. The stock surged over 40% in the days following inclusion, but accumulated profit-taking led to sustained pullbacks starting September 10, with declines exceeding 5% recorded on both September 11 and September 14. After this extended period of selling, short-term downside pressure appears to have eased, triggering the current technical rebound.

Notably, the broader Biotechnology sector where METIS TECHBIO-P operates remained subdued, with AKESO down 0.89%, LEADS BIOLABS-B down 4.06%, INNOVENT BIO down 0.41%, BEONE MEDICINES down 0.09%, and REMEGEN down 0.53%, suggesting the rebound is stock-specific rather than sector-driven.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)